Streetbeat News

Earnings

XXII

22nd Century Group reported a Q4 GAAP EPS of $(0.66), missing the $(0.56) estimate. Sales were $7.36M, which may not be directly comparable to the $17.10M estimate.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:35 am

DRIO

DarioHealth (NASDAQ:DRIO) reported Q4 sales of $3.62M, surpassing the $3.57M estimate, but marking a 46.82% decrease from $6.80M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:35 am

KOD

Kodiak Sciences (NASDAQ:KOD) reported a Q4 EPS loss of $(1.13), missing the consensus estimate of $(0.77) by 46.75%. This represents a 16.3% improvement over the $(1.35) per share loss from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:35 am

MSM

MSC Industrial Supply has maintained its FY24 outlook, projecting ADS growth between 0%-5%, an adjusted operating margin of 12%-12.8%, and an operating cash flow conversion of over 125%.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:33 am

HUT

Hut 8 Corp reported a revenue of $60.6M for the six months ended December 31, 2023, marking a 32% increase year-over-year. The company also reported an EPS of $0.11.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:32 am

GROY

Gold Royalty Corp. forecasts its total revenue for 2024 to be between $10M-$11.2M, which is below the consensus estimate of $11.71M. However, the company anticipates positive operating cash flow for the fiscal year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:32 am

MSM

MSC Industrial Direct Co (MSM) reported Q2 adjusted EPS of $1.18, surpassing the $1.16 estimate, but its sales of $935.30M fell short of the $946.55M estimate. This represents an 18.62% decrease in earnings and a 2.74% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:31 am

GROY

Gold Royalty (AMEX:GROY) reported Q1 adjusted EPS of $0.01, beating estimates of $(0.01), a 150% increase from last year. However, sales of $1.02M missed estimates by 46.53%, despite being a 74.57% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:28 am

ZURA

Zura Bio (NASDAQ:ZURA) reported a Q4 EPS loss of $(2.09), surpassing the $(2.99) estimate, marking a significant improvement from last year's $(141.97) loss per share. The company's cash position of $99.8M is expected to sustain operations into 2026.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:19 am

ATAT

Atour Lifestyle Holdings (NASDAQ:ATAT) reported Q4 adjusted earnings of $0.23 per ADS, surpassing the consensus estimate of $0.19 by 21.05%. This represents a 155.56% increase from the $0.09 per ADS earnings in the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 10:17 am